Tirzepatide: Efficacy and Safety Compared to Other Diabetes Medications

Tirzepatide is a dual GIP and GLP-1 receptor agonist that has been approved by the FDA for the treatment of type 2 diabetes mellitus

. Here are some comparisons of tirzepatide's efficacy and safety to other diabetes medications:

Efficacy

In a global phase 3 trial, patients with obesity and type 2 diabetes or with overweight and type 2 diabetes lost an estimated 34.4 pounds (15.7%) of body weight with 10 mg and 15 mg of tirzepatide
9
.
The SURMOUNT-2 study found that individuals with type 2 diabetes and obesity lost an average of 15% of their body weight after 72 weeks of treatment with tirzepatide
14
.
Tirzepatide has been shown to be effective in improving blood sugar control in adults with type 2 diabetes. In clinical trials, all doses of tirzepatide demonstrated superiority in reducing A1C and body weight from baseline versus placebo or active comparators
5
.

Safety

Tirzepatide has a similar safety profile to other drugs in its class
16
.
Both tirzepatide and semaglutide have boxed warnings for the risk of thyroid C-cell tumors
8
.
There are still questions about the side effects of tirzepatide in people without type 2 diabetes
8
.

Comparison to Other Medications

An adjusted indirect treatment comparison found that tirzepatide 10 and 15 mg significantly reduced HbA1c and body weight versus semaglutide 2 mg
1
.
The Institute for Clinical and Economic Review (ICER) concluded that tirzepatide has "comparable or incremental net health benefits" compared to Ozempic and "comparable or inferior net health benefits" compared to Jardiance
2
.
A systematic review and meta-analysis found that tirzepatide exhibited superior characteristics of lowering HbA1c and fasting serum glucose compared to other diabetes medications
15
.

In summary, tirzepatide has been shown to be effective in reducing body weight and improving blood sugar control in adults with type 2 diabetes. It has a similar safety profile to other drugs in its class, but there are still questions about its side effects in people without type 2 diabetes. Compared to other diabetes medications, tirzepatide has been found to have comparable or superior efficacy in reducing HbA1c and body weight.

Citations:

[1] https://pubmed.ncbi.nlm.nih.gov/35589616/

[2] https://www.fiercepharma.com/pharma/lilly-s-tirzepatide-doesn-t-necessarily-top-diabetes-rivals-jardiance-and-ozempic-icer-says

[3] https://pubmed.ncbi.nlm.nih.gov/34672967/

[4] https://www.nejm.org/doi/full/10.1056/NEJMoa2107519

[5] https://www.drugs.com/compare/tirzepatide

[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159347/

[7] https://www.drugdiscoverytrends.com/tirzepatide-vs-semaglutide-obesity-treatment-showdown/

[8] https://www.healthline.com/health/tirzepatide-vs-semaglutide

[9] https://pubmed.ncbi.nlm.nih.gov/36152639/

[10] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231274/

[11] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987449/

[12] https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

[13] https://nuvoyou.com/blog-1/f/tirzepatide-vs-semaglutide-for-weight-loss-what-you-must-know

[14] https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00243-1/fulltext

[15] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774036/

[16] https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-achieved-157-weight-loss-adults-obesity-or

[17] https://www.practiceupdate.com/content/2021-top-story-in-diabetes-tirzepatide-vs-semaglutide-in-patients-with-type-2-diabetes/128316

[18] https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2021/11/01/03/42/SURPASS-4

[19] https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14775

[20] https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0285197

[21] https://investor.lilly.com/news-releases/news-release-details/tirzepatide-results-published-lancet-show-superior-a1c-and-body

[22] https://www.frontiersin.org/articles/10.3389/fphar.2022.1016639/full

[23] https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-achieves-all-primary-and-key-secondary-study

[24] https://www.nature.com/articles/s41591-023-02344-1

[25] https://clinicaltrials.gov/ct2/show/NCT03730662

[26] https://diabetesjournals.org/clinical/article/41/2/258/148021/Efficacy-and-Safety-of-Tirzepatide-in-Adults-With

[27] https://www.fda.gov/news-events/press-announcements/fda-approves-novel-dual-targeted-treatment-type-2-diabetes

Flying Just Got a Lot More Expensive — and Tariffs Are Only the Beginning

As trade tensions escalate between major economies, new tariff uncertainties are weighing heavily on airlines. The consequences will ripple far beyond boardrooms and airfields: travelers should expect higher ticket prices, fewer route options, and a possible reshaping of the global aviation landscape. Immediate Impacts: Airlines Navigate a New Set of Risks In the short term, airlines are grappling with a complex mix of operational challenges: First, the aircraft supply chain is under pressure. Trade disputes between the United States, the European Union, and China have complicated the procurement of new planes. Manufacturers like Boeing, Airbus, and China's state-backed COMAC are caught in the middle, creating delays and pricing uncertainty for carriers ( Reuters ). Fuel markets are similarly volatile. Airlines typically hedge fuel prices months in advance to avoid sudden cost spikes. However, unpredictable shifts in global oil prices—driven in part by trade instability—are u...

What’s it like to grow up in Vienna, Austria? | Young and European

Key Themes and Insights: City Overview 🏙️ Vienna is often referred to as the 'City of Music' and has consistently been voted the world's most livable city. ✨ The city balances open-mindedness with rich traditions, offering impressive infrastructure and educational opportunities. Living Environment 🏡 Sebi enjoys living in the eighth district, Josefstadt, known for its proximity to the city center but high rental prices. 💰 The average rent in Vienna is €9.80 per square meter, making it relatively affordable compared to other European cities, although this district is an exception. Education System 📚 Sebi attends one of the oldest schools in Vienna, where he studies multiple languages and engages in higher education preparation. 🎓 The average age for Austrians to move out is 25.5 years, with many students like Sebi aspiring to continue their education at nearby universities, such as the University of Vienna. Transportation 🚉 Vienna has an excellent public transport syste...

Why U.S. Tech Giants Are Betting Big on Canadian AI?

Why U.S. Tech Giants Are Betting Big on Canadian AI Imagine this: the most powerful tech companies in the world—Google, Meta, Microsoft—are betting their futures not just in Silicon Valley, but thousands of miles north, in the snowy cities of Canada. Strange, right? Why would billion-dollar U.S. tech giants rely so heavily on Canadian AI labs? What do Canadian researchers have that the tech capitals of California don’t? And could this quiet dependence shift the global tech balance? Let’s dive into a story of brainpower, policy, and a silent AI revolution that began long before most of us even knew what AI was. The Roots of Canada's AI Advantage To understand why U.S. tech titans are now so deeply entwined with Canada’s AI ecosystem, we need to go back to the early days of AI research—in the 1980s and '90s. At that time, the initial hype around artificial intelligence had faded. Funding was drying up globally, and many dismissed AI, especially deep learning, as a dead en...

Munaeem Jamal — Political Analysis & Global Affairs

Search This Blog